Figure 2.
CAAIs as innovative and versatile tools to perturb the allosteric site of Akt. Binding mode of covalent-allosteric ligands, key interactions to the protein, and the auspicious space examined for functional alteration, e.g., optimization of pharmacokinetic characteristics or increase of isoform-selectivity (PDB: 6HHI).